2023
DOI: 10.1111/apt.17544
|View full text |Cite
|
Sign up to set email alerts
|

Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 20 publications
(55 reference statements)
0
2
0
Order By: Relevance
“…Baseline risk factors that have been identified as predictors of poor 1‐year disease outcome in paediatric ulcerative colitis (UC) are severe endoscopic activity, hypoalbuminemia, anaemia, elevated faecal calprotectin and an elevated paediatric UC activity index (PUCAI) 2–5 . This current prospective study explored these baseline predictors in 223 paediatric patients with newly diagnosed UC from two study cohorts 6 . The authors included 17 centres from Europe, the Middle East and Southeast Asia.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Baseline risk factors that have been identified as predictors of poor 1‐year disease outcome in paediatric ulcerative colitis (UC) are severe endoscopic activity, hypoalbuminemia, anaemia, elevated faecal calprotectin and an elevated paediatric UC activity index (PUCAI) 2–5 . This current prospective study explored these baseline predictors in 223 paediatric patients with newly diagnosed UC from two study cohorts 6 . The authors included 17 centres from Europe, the Middle East and Southeast Asia.…”
mentioning
confidence: 99%
“…[2][3][4][5] This current prospective study explored these baseline predictors in 223 paediatric patients with newly diagnosed UC from two study cohorts. 6 The authors included 17 centres from Europe, the Middle East and Southeast Asia. Their main outcomes were steroid-free clinical remission (SFR) at 3 and 12 months, and sus-tainedSFRat1 year.Theyalsoanalysedpredictorsofescalationto biologic therapy, colectomy, and rate of acute severe colitis (ASC).All patients had induction therapy with 5-ASA or steroids; a quarter escalated to biologic therapy within the first year.…”
mentioning
confidence: 99%